Ingrid Kane
Director Técnico/Científico/I+D en SIGHT SCIENCES, INC. .
Cargos activos de Ingrid Kane
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SIGHT SCIENCES, INC. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Ingrid Kane
Antiguos cargos conocidos de Ingrid Kane.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Director Técnico/Científico/I+D | - | - |
Formación de Ingrid Kane.
| University of Charles | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| República Checa | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Health Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SIGHT SCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
- Bolsa de valores
- Insiders
- Ingrid Kane
- Experiencia
